论文信息 - A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE. - 字舞流文

A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE.

Niels H. Wulff | J. Vollmar | P. Chaplin | A. Handley | A. von Krempelhuber | H. Kollaritsch | R. Pokorny | Barbara Petzold | Petra Rapp | Lyn Mateo | Henriette Siersbol